Ramazan Idılman

PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

George Papatheodoridis, George Ν. Dalekos, Vana Sypsa et al. · Journal of Hepatology · 2015 · 541 citations

Medicine, Oncology, Hepatology +13

Hepatic Steatosis: Quantification by Proton Density Fat Fraction with MR Imaging versus Liver Biopsy

Ilkay S. Idılman, Hatice Aniktar, Ramazan Idılman et al. · Radiology · 2013 · 389 citations

Medicine, Pathology, Radiology +17

aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis

Rong Fan, George Papatheodoridis, Jian Sun et al. · Journal of Hepatology · 2020 · 349 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B

George Papatheodoridis, Ramazan Idılman, George Ν. Dalekos et al. · Hepatology · 2017 · 292 citations

Medicine, Oncology, Pharmacotherapy +15

Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial

Christopher Koh, Laëtitia Canini, Harel Dahari et al. · The Lancet Infectious Diseases · 2015 · 263 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12